Impacts of molecular drivers in aortic dissection

Abstract

Background: Aortic dissection (AD) is a lethal cardiovascular emergency involving high mortality and disability. However, its specific pathogenesis remains to be elucidated.

Methods: A bibliometric analysis based on the Web of Science database, VOSviewer software and Citex platforms was conducted to have a knowledge of the development trends, frontiers and hot spots of AD. Subsequently, the top five AD-related genes from the titles and abstracts of published literature were searched. Lastly, the roles of the top five genes and their encoded proteins in the onset of AD were reviewed.

Results: The bibliometrics showed that most studies are exploring the molecular drivers related to AD, especially gene mutations. The top five AD-related genes were transforming growth factor-β (TGFB)-related genes, elastin (ELN), fibrillin-1 (FBN1), angiotensinogen (AGT) and matrix metalloproteinase 9 (MMP9). In particular, regulation of the structure of elastic fiber by TGFB-related genes, ELN and FBN1, appears to be the principal mechanism contributing to AD onset. Activation of the renin-angiotensin system is the principal mechanism by which AGT triggers AD. MMP9 promotes the formation and development of AD by degrading extracellular matrix components.

Conclusion: TGFB, ELN, FBN1, AGT and MMP9 are the five top molecular drivers of AD, providing a comprehensive mechanistic insight into AD.

Keywords

AGT / aortic dissection / ELN / FBN1 / MMP9 / molecular drivers / TGFB

References

[1] Nienaber CA, Clough RE, Sakalihasan N, et al. Aortic dissection. Nat Rev Dis Primers. 2016;2(1):16053.

[2] Gouveia EMR, Mourão M, Caldeira D, et al. A systematic review and meta-analysis of the incidence of acute aortic dissections in population-based studies. J Vasc Surg. 2022;75(2):709-720.

[3] Kaeley N, Gangdev A, Galagali SS, Kabi A, Shukla K. Atypical presentation of aortic dissection in a young female and the utility of point-of-care ultrasound in identifying aortic dissection in the emergency department. Cureus. 2022;14(7):e27236.

[4] Grommes J, Greiner A, Bendermacher B, et al. Risk factors for mortality and failure of conservative treatment after aortic type B dissection. J Thorac Cardiovasc Surg. 2014;148(5):2155-2160. e1.

[5] Zhu Y, Lingala B, Baiocchi M, et al. Type A aortic dissection-experience over 5 decades: JACC historical breakthroughs in perspective. J Am Coll Cardiol. 2020;76(14):1703-1713.

[6] David TE. Adventitial inversion in the distal anastomosis in surgical treatment of acute DeBakey type I aortic dissection. J Thorac Cardiovasc Surg. 2016;151(5):1346-1347.

[7] Gawinecka J, Schönrath F, von Eckardstein A. Acute aortic dissection: pathogenesis, risk factors and diagnosis. Swiss Med Wkly. 2017;147:w14489.

[8] Chakraborty A, Li Y, Zhang C, et al. Epigenetic induction of smooth muscle cell phenotypic alterations in aortic aneurysms and dissections. Circulation. 2023;148(12):959-977.

[9] An Z, Liu Y, Song ZG, Tang H, Yuan Y, Xu ZY. Mechanisms of aortic dissection smooth muscle cell phenotype switch. J Thorac Cardiovasc Surg. 2017;154(5):1511-1521.e6.

[10] Ge X, Cai Q, Cai Y, Mou C, Fu J, Lin F. Roles of pyroptosis and immune infiltration in aortic dissection. Front Mol Biosci. 2024;11:1277818.

[11] Pan L, Lin Z, Tang X, et al. S-Nitrosylation of plastin-3 exacerbates thoracic aortic dissection formation via endothelial barrier dysfunction. Arterioscler Thromb Vasc Biol. 2020;40(1):175-188.

[12] Yin ZQ, Han H, Yan X, Zheng QJ. Research progress on the pathogenesis of aortic dissection. Curr Probl Cardiol. 2023;48(8):101249.

[13] Chakraborty A, Li Y, Zhang C, Li Y, LeMaire SA, Shen YH. Programmed cell death in aortic aneurysm and dissection: a potential therapeutic target. J Mol Cell Cardiol. 2022;163:67-80.

[14] Chen Y, Yi X, Wei X, Jiang DS. Ferroptosis: a novel pathological mechanism of aortic dissection. Pharmacol Res. 2022;182:106351.

[15] Lee J, Yoon W, Kim S, et al. BioBERT: a pre-trained biomedical language representation model for biomedical text mining. Bioinformatics. 2020;36(4):1234-1240.

[16] Takeda N, Hara H, Fujiwara T, Kanaya T, Maemura S, Komuro I. TGF-β signaling-related genes and thoracic aortic aneurysms and dissections. Int J Mol Sci. 2018;19(7).

[17] Tingting T, Wenjing F, Qian Z, et al. The TGF-β pathway plays a key role in aortic aneurysms. Clin Chim Acta. 2020;501:222-228.

[18] Gao P, Wu W, Ye J, et al. Transforming growth factor β1 suppresses proinflammatory gene program independent of its regulation on vascular smooth muscle differentiation and autophagy. Cell Signal. 2018;50:160-170.

[19] Chen J, Chang R. Association of TGF-β canonical signaling-related core genes with aortic aneurysms and aortic dissections. Front Pharmacol. 2022;13:888563.

[20] Frutkin AD, Otsuka G, Stempien-Otero A, et al. TGF-[beta]1 limits plaque growth, stabilizes plaque structure, and prevents aortic dilation in apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol. 2009;29(9):1251-1257.

[21] Serralheiro P, Cairrão E, Maia CJ, João M, Almeida CMC, Verde I. Effect of TGF-beta1 on MMP/TIMP and TGF-beta1 receptors in great saphenous veins and its significance on chronic venous insufficiency. Phlebology. 2017;32(5):334-341.

[22] Norton EL, Hornsby WE, Wu X, et al. Aortic progression and reintervention in patients with pathogenic variants after a thoracic aortic dissection. J Thorac Cardiovasc Surg. 2021;162(5):1436-1448.e6.

[23] Boileau C, Guo DC, Hanna N, et al. TGFB2 mutations cause familial thoracic aortic aneurysms and dissections associated with mild systemic features of Marfan syndrome. Nat Genet. 2012;44(8):916-921.

[24] Lin CJ, Lin CY, Stitziel NO. Genetics of the extracellular matrix in aortic aneurysmal diseases. Matrix Biol. 2018;71-72:128-143.

[25] Rojas HA, Fernandes K, Ottone MR, et al. Levels of MMP-9 in patients with intracranial aneurysm: relation with risk factors, size and clinical presentation. Clin Biochem. 2018;55:63-68.

[26] Milewicz DM, Braverman AC, De Backer J, et al. Marfan syndrome. Nat Rev Dis Primers. 2021;7(1):64.

[27] Arnaud P, Morel H, Milleron O, et al. Unsuspected somatic mosaicism for FBN1 gene contributes to Marfan syndrome. Genet Med. 2021;23(5):865-871.

[28] Regalado ES, Guo DC, Santos-Cortez RL, et al. Pathogenic FBN1 variants in familial thoracic aortic aneurysms and dissections. Clin Genet. 2016;89(6):719-723.

[29] Milewicz DM, Michael K, Fisher N, Coselli JS, Markello T, Biddinger A. Fibrillin-1 (FBN1) mutations in patients with thoracic aortic aneurysms. Circulation. 1996;94(11):2708-2711.

[30] Salmasi MY, Alwis S, Cyclewala S, et al. The genetic basis of thoracic aortic disease: the future of aneurysm classification? Hellenic J Cardiol. 2023;69:41-50.

[31] LeMaire SA, McDonald ML, Guo DC, et al. Genome-wide association study identifies a susceptibility locus for thoracic aortic aneurysms and aortic dissections spanning FBN1 at 15q21.1. Nat Genet. 2011;43(10):996-1000.

[32] Brautbar A, LeMaire SA, Franco LM, Coselli JS, Milewicz DM, Belmont JW. FBN1 mutations in patients with descending thoracic aortic dissections. Am J Med Genet A. 2010;152a(2):413-416.

[33] Ashworth JL, Kelly V, Wilson R, Shuttleworth CA, Kielty CM. Fibrillin assembly: dimer formation mediated by amino-terminal sequences. J Cell Sci. 1999;112(Pt 20):3549-3558.

[34] Lesauskaite V, Sepetiene R, Jariene G, et al. FBN1 polymorphisms in patients with the dilatative pathology of the ascending thoracic aorta. Eur J Cardiothorac Surg. 2015;47(4):e124-e130.

[35] Okuno K, Torimoto K, Cicalese SM, et al. Angiotensin II type 1A receptor expressed in smooth muscle cells is required for hypertensive vascular remodeling in mice infused with angiotensin II. Hypertension. 2023;80(3):668-677.

[36] Yang K, Ren J, Li X, et al. Prevention of aortic dissection and aneurysm via an ALDH2-mediated switch in vascular smooth muscle cell phenotype. Eur Heart J. 2020;41(26):2442-2453.

[37] Li H, Xu H, Wen H, et al. Lysyl hydroxylase 1 (LH1) deficiency promotes angiotensin II (Ang II)-induced dissecting abdominal aortic aneurysm. Theranostics. 2021;11(19):9587-9604.

[38] Yang L, Wu H, Luo C, et al. Urate-lowering therapy inhibits thoracic aortic aneurysm and dissection formation in mice. Arterioscler Thromb Vasc Biol. 2023;43(6):e172-e189.

[39] Zhou X, Cheng J, Chen Z, et al. Role of c-Abl in Ang II-induced aortic dissection formation: potential regulatory efficacy on phenotypic transformation and apoptosis of VSMCs. Life Sci. 2020;256:117882.

[40] Li X, Liu D, Zhao L, et al. Targeted depletion of monocyte/macrophage suppresses aortic dissection with the spatial regulation of MMP-9 in the aorta. Life Sci. 2020;254:116927.

[41] Tomida S, Aizawa K, Nishida N, et al. Indomethacin reduces rates of aortic dissection and rupture of the abdominal aorta by inhibiting monocyte/macrophage accumulation in a murine model. Sci Rep. 2019;9(1):10751.

[42] Wang T, He X, Liu X, et al. Weighted gene co-expression network analysis identifies FKBP11 as a key regulator in acute aortic dissection through a NF-kB dependent pathway. Front Physiol. 2017;8:1010.

[43] Shan L, Wang F, Zhai D, Meng X, Liu J, Lv X. Matrix metalloproteinases induce extracellular matrix degradation through various pathways to alleviate hepatic fibrosis. Biomed Pharmacother. 2023;161:114472.

[44] Yin Z-Q, Han H, Yan X, Zheng Q-J. Research progress on the pathogenesis of aortic dissection. Curr Probl Cardiol. 2023;48(8):101249.

[45] Cabral-Pacheco GA, Garza-Veloz I, Castruita-De la Rosa C, et al. The roles of matrix metalloproteinases and their inhibitors in human diseases. Int J Mol Sci. 2020;21(24):9739.

[46] Kurihara T, Shimizu-Hirota R, Shimoda M, et al. Neutrophil-derived matrix metalloproteinase 9 triggers acute aortic dissection. Circulation. 2012;126(25):3070-3080.

[47] Hu Y, Lu L, Qiu Z, Huang Q, Chen Y, Chen L. Mechanical stretch aggravates aortic dissection by regulating MAPK pathway and the expression of MMP-9 and inflammation factors. Biomed Pharmacother. 2018;108:1294-1302.

[48] Li T, Li X, Feng Y, Dong G, Wang Y, Yang J. The role of matrix metalloproteinase-9 in atherosclerotic plaque instability. Mediators Inflamm. 2020;2020:3872367.

[49] Ying W. Phenomic studies on diseases: potential and challenges. Phenomics. 2023;3(3):285-299.

[50] Doudesis D, Lee KK, Boeddinghaus J, et al. Machine learning for diagnosis of myocardial infarction using cardiac troponin concentrations. Nat Med. 2023;29(5):1201-1210.

[51] Choi J, Tayob N, Lim YS. Detecting early hepatocellular carcinoma in patients with chronic hepatitis B using longitudinal α-fetoprotein screening. Clin Gastroenterol Hepatol. 2023;21(6):1590-1597.

RIGHTS & PERMISSIONS

2024 2024 The Author(s). Clinical and Translational Discovery published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.